These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21755189)

  • 21. Importance of Nebulizer Drying for Patients With Cystic Fibrosis.
    Moore JE; Moore RE; Bell J; Millar BC
    Respir Care; 2020 Oct; 65(10):1443-1450. PubMed ID: 32209705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of the
    Moore JE; Millar BC
    Int J Mycobacteriol; 2020; 9(2):173-175. PubMed ID: 32474539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ozone disinfection of home nebulizers effectively kills common cystic fibrosis bacterial pathogens.
    Towle D; Baker V; Schramm C; O'Brien M; Collins MS; Feinn R; Murray TS
    Pediatr Pulmonol; 2018 May; 53(5):599-604. PubMed ID: 29542874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Disinfection of devices for nebulization: stakes, difficulties, and improvement proposals].
    Reychler G; Dupont C; Dubus JC; ;
    Rev Mal Respir; 2007 Dec; 24(10):1351-61. PubMed ID: 18216754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated hot water and steam disinfection of Pari LC Plus® nebulizers alter nebulizer output.
    Collins MS; O'Brien M; Schramm CM; Murray TS
    J Cyst Fibros; 2019 Mar; 18(2):233-235. PubMed ID: 30224332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis.
    Gilljam H; Malmborg AS; Strandvik B
    Thorax; 1986 Aug; 41(8):641-6. PubMed ID: 3097864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebulizer use and maintenance by cystic fibrosis patients: a survey study.
    Lester MK; Flume PA; Gray SL; Anderson D; Bowman CM
    Respir Care; 2004 Dec; 49(12):1504-8. PubMed ID: 15571641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Throat Swabs and Sputum Culture as Predictors of P. aeruginosa or S. aureus Lung Colonization in Adult Cystic Fibrosis Patients.
    Seidler D; Griffin M; Nymon A; Koeppen K; Ashare A
    PLoS One; 2016; 11(10):e0164232. PubMed ID: 27711152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial reservoirs in cystic fibrosis.
    Taylor CJ; McGaw J; Howden R; Duerden BI; Baxter PS
    Arch Dis Child; 1990 Feb; 65(2):175-7. PubMed ID: 2317061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial Colonization of Home Nebulizers Used by Children With Recurrent Wheeze.
    Ranjan N; Singla N; Guglani V; Randev S; Kumar P
    Indian Pediatr; 2022 May; 59(5):377-379. PubMed ID: 35348123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis.
    Denton M; Rajgopal A; Mooney L; Qureshi A; Kerr KG; Keer V; Pollard K; Peckham DG; Conway SP
    J Hosp Infect; 2003 Nov; 55(3):180-3. PubMed ID: 14572484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baby bottle steam sterilizers disinfect home nebulizers inoculated with bacterial respiratory pathogens.
    Towle D; Callan DA; Farrel PA; Egan ME; Murray TS
    J Cyst Fibros; 2013 Sep; 12(5):512-6. PubMed ID: 23267773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial contamination of spacer devices used by asthmatic children.
    Cohen HA; Cohen Z; Pomeranz AS; Czitron B; Kahan E
    J Asthma; 2005 Apr; 42(3):169-72. PubMed ID: 15962872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of Staphylococcus aureus (MSSA and MRSA) to drying: implications for nebulizer hygiene in patients with cystic fibrosis.
    Moore JE; Millar BC
    J Hosp Infect; 2020 Jun; 105(2):366-367. PubMed ID: 32298736
    [No Abstract]   [Full Text] [Related]  

  • 35. Bacterial contamination in the environment of hospitalised children with cystic fibrosis.
    Ferroni A; Werkhauser-Bertrand A; Le Bourgeois M; Beauvais R; Vrielynck S; Durand C; Lenoir G; Berche P; Sermet-Gaudelus I
    J Cyst Fibros; 2008 Nov; 7(6):477-82. PubMed ID: 18550452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cleaning of inpatient nebulizer devices in cystic fibrosis patients: the urgent need for universal guidelines.
    Bell J; Moore JE; Millar BC
    J Hosp Infect; 2018 Nov; 100(3):e64-e66. PubMed ID: 30369424
    [No Abstract]   [Full Text] [Related]  

  • 37. Isolation of Staphylococcus aureus from sputum in cystic fibrosis.
    Sparham PD; Lobban DI; Speller DC
    J Clin Pathol; 1978 Oct; 31(10):913-8. PubMed ID: 101553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
    Greenwood J; Schwarz C; Sommerwerck U; Nash EF; Tamm M; Cao W; Mastoridis P; Debonnett L; Hamed K
    Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis.
    Hutchinson GR; Parker S; Pryor JA; Duncan-Skingle F; Hoffman PN; Hodson ME; Kaufmann ME; Pitt TL
    J Clin Microbiol; 1996 Mar; 34(3):584-7. PubMed ID: 8904419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.